November 17, 2022 (Earnings Report) Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Atkore International Group
Symbol: ATKR
Recent Price: $104.61
Average Analyst Price Target: $104.67 (0.06%)
Market Cap: $4.40B
Last Year's EPS: $4.39
Consensus EPS Forecast: $5.08
Expected Earnings Date: Nov 17 2022
Recent Analyst Action: Chris Dankert, analyst at Loop Capital Markets, reiterates coverage on Atkore International Group (ATKR) in the Industrial Goods sector with a Buy rating and a price target of $ 110 (4 weeks ago).
TipRanks.com also reports that Atkore International Group currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $104.67 . The target pricing ranges from a high forecast of $110.00 down to a low forecast of $94.00. Atkore International Group (ATKR)’s last closing price was $104.61 which would put the average price target at 0.06% upside.Here are 3rd party ratings for ATKR:
Recent Analyst Action: Michael Binetti, analyst at Credit Suisse, reiterates coverage on Foot Locker (FL) in the Consumer Goods sector with a Hold rating and a price target of n/a (17 hours ago).
TipRanks.com also reports that Foot Locker currently has 17 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $35.63 . The target pricing ranges from a high forecast of $43.00 down to a low forecast of $29.00. Foot Locker (FL)’s last closing price was $31.43 which would put the average price target at 13.36% upside.Here are 3rd party ratings for FL:
Recent Analyst Action: Christopher Carey, analyst at Wells Fargo, reiterates coverage on Spectrum Brands Holdings (SPB) in the Consumer Goods sector with a Buy rating and a price target of $ 70 (1 month ago).
TipRanks.com also reports that Spectrum Brands Holdings currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $69.00 . The target pricing ranges from a high forecast of $70.00 down to a low forecast of $68.00. Spectrum Brands Holdings (SPB)’s last closing price was $49.99 which would put the average price target at 38.03% upside.Here are 3rd party ratings for SPB:
Recent Analyst Action: James Lee, analyst at Mizuho Securities, reiterates coverage on JD (JD) in the Consumer Goods sector with a Buy rating and a price target of $ 82 (2 days ago).
TipRanks.com also reports that JD currently has 13 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $79.54 . The target pricing ranges from a high forecast of $109.00 down to a low forecast of $55.00. JD (JD)’s last closing price was $53.49 which would put the average price target at 48.70% upside.Here are 3rd party ratings for JD:
Recent Analyst Action: Irma Sgarz, analyst at Goldman Sachs, reiterates coverage on Afya (AFYA) in the Services sector with a Buy rating and a price target of $ 13.5 (2 months ago).
TipRanks.com also reports that Afya currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $15.25 . The target pricing ranges from a high forecast of $17.00 down to a low forecast of $13.50. Afya (AFYA)’s last closing price was $16.06 which would put the average price target at -5.04% upside.Here are 3rd party ratings for AFYA:
Recent Analyst Action: Puneet Souda, analyst at SVB Securities, reiterates coverage on Twist Bioscience (TWST) in the Healthcare sector with a Hold rating and a price target of $ 45 (1 month ago).
TipRanks.com also reports that Twist Bioscience currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $45.00 . The target pricing ranges from a high forecast of $45.00 down to a low forecast of $45.00. Twist Bioscience (TWST)’s last closing price was $28.29 which would put the average price target at 59.07% upside.Here are 3rd party ratings for TWST:
Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on Xenetic Biosciences (XBIO) in the Healthcare sector with a Buy rating and a price target of $ 4 (6 days ago).
TipRanks.com also reports that Xenetic Biosciences currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $4.00 . The target pricing ranges from a high forecast of $4.00 down to a low forecast of $4.00. Xenetic Biosciences (XBIO)’s last closing price was $0.44 which would put the average price target at 809.09% upside.Here are 3rd party ratings for XBIO:
To Your Financial Future,
The Editor, DailyStockmovers.com